Back to results
US 8,476,315 B2Granted
N-hydroxy C29-amide derivatives of oleandrane
AssigneeOnepharm Research and Development GmbH
InventorsPaul Kosma, Ulrich Jordis, Dirk Classen-Houben, Bernhard Kueenburg, Christian Stanetty, Laszlo Czollner
Life of this patent
Estimating the term…
Abstract
The present invention encompasses novel triterpene compounds of general formula I, wherein R3a, R3b, R11a, R11b, R31 and R32 are defined as in claim 1, which are suitable for the prevention and/or treatment of diseases mediated by 11 β-HSD and the use thereof for preparing a medicament having the above-mentioned properties.
Claims14
A compound having the following general structural formula I,
- wherein:
- R3a and R3b together are selected from ═O, ═NRa, ═N—O—Ra;
- or R3a and R3b are independently from one another selected from hydrogen, —O—Ra, —O—C(═O)—Ra, —NH—Ra, —NH—O—Ra, —NH—C(═O)—Ra and —NH—S(═O)2Ra;
- and
- R11a and R11b together are selected from ═O, ═NRa, ═N—O—Ra;
- or R11a and R11b are independently from one another selected from hydrogen, —O—Ra, —O—C(═O)—Ra, —NH—Ra, methyl, ethyl, ethynyl, fluorine, chlorine, and bromine;
- and a single or double bond is present at 12-13;
- R31 is selected from hydrogen, hydroxyalkyl, C1-6 alkyl, C2-6 alkenyl, C2-8 alkynyl, —CF3, —(CH2)n—C6-14 aryl, —CH═CH—C6-14 aryl, —C≡C—C6-14 aryl, —(CH2)n—C5-14 heteroaryl, —CH═CH—C5-14 heteroaryl, —C≡C—C5-14 heteroaryl, carboxylic acid, —(CH2)n—C3-8 cycloalkyl, —CH═CH—C3-8 cycloalkyl and —C≡C—C3-8 cycloalkyl;
- and
- R32 is hydrogen or selected from optionally substituted hydroxyalkyl, C1-6 alkyl, C2-6 alkenyl, C2-8 alkynyl, —CF3, —(CH2)n—C6-14 aryl, —CH═CH—C6-14 aryl, —C≡C—C6-14 aryl, —(CH2)n—C5-14 heteroaryl, —CH═CH—C5-14heteroaryl, —C≡C—C5-14 heteroaryl, carboxylic acid, —(CH2)n—C3-8 cycloalkyl, —CH═CH—C3-8cycloalkyl and —C≡C—C3-8cycloalkyl;
- Ra is selected from hydrogen, hydroxyalkyl, C1-6 alkyl, C2-6 alkenyl, C2-8 alkynyl, —CF3, —(CH2)n—C6-14 aryl, —CH═CH—C6-14 aryl, —C≡C—C6-14 aryl, —(CH2)n—C5-14heteroaryl, —CH═CH—C5-14heteroaryl, —C≡C—C5-14heteroaryl, carboxylic acid, —(CH2)n—C3-8cycloalkyl, —CH═CH—C3-8cycloalkyl and —C≡C—C3-8cycloalkyl;
- and
- each n independently of one another denotes 0, 1 or 2,
- including pharmaceutically effective salts, solvates, prodrugs, tautomers, racemates, enantiomers, diastereomers and mixtures thereof, with the proviso that compounds (3S, 18R, 20S)-3-(acetyloxy)-N-hydroxy-11-oxo-olean-12-en-29-amide and (3S, 18R, 20S)-3-(hydroxy)-N-hydroxy-11-oxo-olean-12-en-29-amide are not encompassed.
11 more elements
Dependencies are inferred from the claim text.